119 related articles for article (PubMed ID: 1977322)
1. Lack of effect of hyperglycemia on lipolysis in humans.
Caruso M; Divertie GD; Jensen MD; Miles JM
Am J Physiol; 1990 Oct; 259(4 Pt 1):E542-7. PubMed ID: 1977322
[TBL] [Abstract][Full Text] [Related]
2. Insulin regulation of lipolysis in nondiabetic and IDDM subjects.
Jensen MD; Caruso M; Heiling V; Miles JM
Diabetes; 1989 Dec; 38(12):1595-601. PubMed ID: 2573554
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of hyperglycemia on lipolysis in humans.
Cersosimo E; Coppack S; Jensen M
Am J Physiol; 1993 Dec; 265(6 Pt 1):E821-4. PubMed ID: 8279535
[TBL] [Abstract][Full Text] [Related]
4. Effects of glucagon on free fatty acid metabolism in humans.
Jensen MD; Heiling VJ; Miles JM
J Clin Endocrinol Metab; 1991 Feb; 72(2):308-15. PubMed ID: 1991802
[TBL] [Abstract][Full Text] [Related]
5. Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans.
Divertie GD; Jensen MD; Cryer PE; Miles JM
Am J Physiol; 1997 Jun; 272(6 Pt 1):E1130-5. PubMed ID: 9227461
[TBL] [Abstract][Full Text] [Related]
6. The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.
Avogaro A; Valerio A; Gnudi L; Maran A; Miola M; Duner E; Marescotti C; Iori E; Tiengo A; Nosadini R
Diabetologia; 1992 Feb; 35(2):129-38. PubMed ID: 1547916
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
[TBL] [Abstract][Full Text] [Related]
8. Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects.
Hawkins M; Gabriely I; Wozniak R; Reddy K; Rossetti L; Shamoon H
Diabetes; 2002 Jul; 51(7):2179-89. PubMed ID: 12086948
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of lipolysis in humans by physiological hypercortisolemia.
Divertie GD; Jensen MD; Miles JM
Diabetes; 1991 Oct; 40(10):1228-32. PubMed ID: 1936585
[TBL] [Abstract][Full Text] [Related]
10. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
11. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
[TBL] [Abstract][Full Text] [Related]
12. Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans.
Davis MR; Shamoon H
Metabolism; 1992 Feb; 41(2):216-23. PubMed ID: 1736045
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia per se can reduce plasma free fatty acid and glycerol levels in the acutely insulin-deficient dog.
Park KS; Rhee BD; Lee KU; Lee HK; Koh CS; Min HK
Metabolism; 1990 Jun; 39(6):595-7. PubMed ID: 2191188
[TBL] [Abstract][Full Text] [Related]
14. Lack of effects of hyperglycemia on the disposal of 3-hydroxybutyrate in insulin-dependent diabetic patients.
Møller N; Jørgensen JO; Møller J; Orskov L; Pørksen N; Alberti KG; Schmitz O
Acta Endocrinol (Copenh); 1990 Dec; 123(6):629-32. PubMed ID: 2284887
[TBL] [Abstract][Full Text] [Related]
15. Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes.
Hawkins M; Gabriely I; Wozniak R; Vilcu C; Shamoon H; Rossetti L
Diabetes; 2002 Mar; 51(3):606-14. PubMed ID: 11872657
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance in type 1 (insulin-dependent) diabetes: dissimilarities for glucose and intermediary metabolites.
Nijs HG; Radder JK; Poorthuis BJ; Krans HM
Diabetes Res; 1990 Sep; 15(1):15-9. PubMed ID: 2132195
[TBL] [Abstract][Full Text] [Related]
17. Regulation of free fatty acid metabolism by glucagon.
Carlson MG; Snead WL; Campbell PJ
J Clin Endocrinol Metab; 1993 Jul; 77(1):11-5. PubMed ID: 8100827
[TBL] [Abstract][Full Text] [Related]
18. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
Basu R; Basu A; Nielsen M; Shah P; Rizza RA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
[TBL] [Abstract][Full Text] [Related]
19. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
Mevorach M; Giacca A; Aharon Y; Hawkins M; Shamoon H; Rossetti L
J Clin Invest; 1998 Aug; 102(4):744-53. PubMed ID: 9710443
[TBL] [Abstract][Full Text] [Related]
20. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
